The expanding field of immunotherapy relies heavily on recombinant mediator technology, and a detailed understanding of individual profiles is essential for optimizing experimental design and therapeutic efficacy. https://nimmansocial.com/story10981679/analyzing-recombinant-cytokine-profiles-il-1a-il-1b-il-2-and-il-3